Antimicrobial resistant infections (AMRs) currently claim at least 50.000 lives each year in Europe and the US alone, and many hundreds of thousands more die in other areas of the world. In 15 European countries, more than 10% of Staphylococcus aureus infections in the bloodstream are caused by methicillin-resistant strains (MRSA),








To date, there is no effective prophylactic agent to prevent COVID-19. However, the development of symptoms similar to covid19 could be prevented with an aqueous solution of chlorine dioxide (ClO2). This retrospective study evaluated the efficacy of an aqueous solution of ClO2 (CDS) as a prophylactic agent in 1.163 relatives living with COVID19 positive / suspected patients.





